Fortress Biotech, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2024 | 0 | $0.00 | $0.00 | $0.00 |
Fortress Biotech, Inc. Earnings Date And Information
Fortress Biotech, Inc. last posted its earnings results on Monday, August 10th, 2020. The company reported $-0.19 earnings per share for the quarter, topping analysts' consensus estimates of $-0.27 by $0.08. The company had revenue of 14.63 M for the quarter and had revenue of 84.51 M for the year. Fortress Biotech, Inc. has generated $-8 earnings per share over the last year ($-8.47 diluted earnings per share) and currently has a price-to-earnings ratio of -0.61. Fortress Biotech, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based on prior year's report dates.
Fortress Biotech, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.76 | $32.22 M | $14.63 M | ||
| 08/13/2024 | Q2 2024 | -$0.73 | $14.90 M | |||
| 05/15/2024 | Q1 2024 | -$1.03 | $13.03 M | |||
| 03/28/2024 | Q4 2023 | -$0.86 | $19.95 M | |||
| 09/29/2023 | Q3 2023 | -$0.67 | $34.75 M | |||
| 08/14/2023 | Q2 2023 | -$3.36 | $17.39 M | |||
| 05/15/2023 | Q1 2023 | -$3.26 | $12.43 M | |||
| 03/31/2023 | Q4 2022 | -$7.80 | $16.40 M | |||
| 11/14/2022 | Q3 2022 | -$2.96 | $16.53 M | |||
| 08/11/2022 | Q2 2022 | -$2.83 | $18.89 M | |||
| 05/12/2022 | Q1 2022 | -$1.70 | $23.93 M | |||
| 03/28/2022 | Q4 2021 | -$5.66 | $18.28 M | |||
| 11/15/2021 | Q3 2021 | -$3.83 | $21.09 M | |||
| 08/16/2021 | Q2 2021 | -$0.65 | $17.84 M | |||
| 05/17/2021 | Q1 2021 | -$1.64 | $11.59 M | |||
| 03/31/2021 | Q4 2020 | -$1.00 | $13.75 M | |||
| 11/09/2020 | Q3 2020 | -$3.06 | $9.48 M | |||
| 08/10/2020 | Q2 2020 | -$0.27 | -$2.91 | -2.64 | $9.46 M | |
| 05/11/2020 | Q1 2020 | -$0.23 | -$2.92 | -2.69 | $12.92 M | |
| 03/16/2020 | Q4 2019 | -$0.31 | -$3.89 | -3.58 | $11.13 M |
Fortress Biotech, Inc. Earnings: Frequently Asked Questions
-
When is Fortress Biotech, Inc.'s earnings date?
Fortress Biotech, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates.
-
Did Fortress Biotech, Inc. beat their earnings estimates last quarter?
In the previous quarter, Fortress Biotech, Inc. (:FBIOP) reported $-0.19 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.27 by $0.08.
-
How can I listen to Fortress Biotech, Inc.'s earnings conference call?
The conference call for Fortress Biotech, Inc.'s latest earnings report can be listened to online.
-
How can I read Fortress Biotech, Inc.'s conference call transcript?
The conference call transcript for Fortress Biotech, Inc.'s latest earnings report can be read online.
-
How much revenue does Fortress Biotech, Inc. generate each year?
Fortress Biotech, Inc. (:FBIOP) has a recorded annual revenue of $84.51 M.
-
How much profit does Fortress Biotech, Inc. generate each year?
Fortress Biotech, Inc. (:FBIOP) has a recorded net income of $84.51 M. Fortress Biotech, Inc. has generated $-8.47 earnings per share over the last four quarters.
-
What is Fortress Biotech, Inc.'s price-to-earnings ratio?
Fortress Biotech, Inc. (:FBIOP) has a price-to-earnings ratio of -0.61 and price/earnings-to-growth ratio is 0.22.
